Västra Hamnen Corporate Finance has published a research update on Heliospectra AB following the company’s full-year report for 2020. The company has successfully adapted its cost base to the circumstances and is now positioned to take advantage of rising demand once the pandemic wanes. We maintain our valuation interval SEK 5.00 – 7.50 per share, writes Västra Hamnen.
- Ending 2020 with revenues and order intake on the rise
- Strong cash position following Q4 rights issue of SEK 50.6 million
- We reiterate our fair value interval of SEK 5.00 – 7.50 per share
Last week, Heliospectra released its full year report for 2020 and the report came in roughly as expected. Although the top line fell slightly short of our estimate, the bottom line came in stronger than we had foreseen, mainly due to better cost control during the period. The company was undoubtedly hit hard by the pandemic, and it is now encouraging to see that both sales and the order intake is starting to accelerate again. With a SEK 50.6 million capital injection providing the company with a strong financial position, we believe the company is on the right track to successfully take on 2021.
The full report is available here.
The research report is prepared as part of Market Focus, Västra Hamnen Corporate Finance’s commissioned research offering.
This is a press release from Västra Hamnen Corporate Finance AB.
Web: vhcorp.se
Twitter: @vhcorp_se